Journal of Viral Hepatitis

Articles Available on Medscape

• Antiviral Treatment for Hepatitis C Is Associated With a Reduced Risk of Atherosclerotic Cardiovascular Outcomes
  Hepatitis C virus infection has been associated with a greater risk of cardiovascular disease. Might antiviral therapy reduce the risk?

  April 09, 2021

• Proton Pump Inhibitor Usage Reduces Sustained Viral Response Rates for Veterans With HIV/HCV Coinfection on Ledipasvir/Sofosbuvir
  This study reveals that PPI use is associated with reduced SVR after LDV/SOF treatment, with a significant impact in patients with HIV/HCV coinfection.

  April 02, 2021

• High Rates of Sustained Virological Response Despite Premature Discontinuation of Directly Acting Antivirals in HCV-infected Patients Treated in a Real-life Setting
  This study showed that despite early discontinuation of DAAs, high SVR rates were observed in a real-life setting for treatment lasting at least 4 weeks in patients with HCV.

  March 18, 2021

• Comparison of Liver Disease State Progression in Patients With Eradication of Versus Persistent Infection With Hepatitis C Virus
  This study investigated the long-term prognosis of liver disease in patients with HCV eradication after antiviral therapy versus those with persistent HCV infection.

  March 15, 2021

• Circulating Cell-free DNA Species Affect the Risk of Hepatocellular Carcinoma in Treated Chronic Hepatitis B Patients
  This study investigated whether different species of serum circulating cfDNA may be involved in the process of hepatocarcinogenesis in chronic HBV patients receiving oral antiviral therapy.

  March 11, 2021

Table of Contents

2021 -

• The impact of DAA-mediated HCV eradication on CD4+ and CD8+ T lymphocyte trajectories in HIV/HCV coinfected patients: data from the ICONA Foundation Cohort. 

  February 18, 2021

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Reduction in hepatitis C-related hospitalisations after the implementation of the Strategic Plan for Tackling Hepatitis C in the Spanish National Health System: regional level differences. 

  February 18, 2021

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Analytical validation of hepatitis B core-related antigen (HBcrAg) using dried blood spots (DBS). 

  February 17, 2021

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Hepatitis C treatment in a co-located mental health and alcohol and drug service using a nurse-led model of care. 

  February 17, 2021

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Clinical effects of NTCP-inhibitor myrcludex B. 

  February 17, 2021

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Changes in the estimated renal function after hepatitis C virus eradication with direct-acting antiviral agents: Impact of changes in skeletal muscle mass. 

  February 15, 2021

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• A multimedia multilanguage web-based platform can assess and increase the awareness on HCV infection of Pakistani people living in Italy. 

  February 15, 2021

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Validation of the HCC-RESCUE Score to Predict Hepatocellular Carcinoma Risk in Caucasian Chronic Hepatitis B Patients Under Entecavir or Tenofovir Therapy. 

  February 15, 2021

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Impact of direct acting antiviral regimens on mortality and morbidity outcomes in patients with chronic hepatitis C: systematic review and meta-analysis. 

  February 08, 2021

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Benefit of transaminase elevations in establishing functional cure of HBV infection during NAP-based combination therapy. 

  February 08, 2021

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Use of healthcare resources and drug expenditure before and after treatment of chronic hepatitis C with direct antiviral agents. 

  February 08, 2021

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Association between nucleos(t)ide analogue therapy for hepatitis B and Sjögren's syndrome: 15-year analysis of the national database of Taiwan. 

  February 06, 2021

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Viral hepatitis C pandemic: challenges and threats to its elimination. 

  February 06, 2021

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Evolutionary seroepidemiology of viral hepatitis and the gap in hepatitis C care cascades among uraemic patients receiving haemodialysis in Taiwan-the Formosa-Like Group. 

  February 03, 2021

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Hepatitis B virus reactivation in cancer patients receiving direct-acting antivirals for hepatitis C virus infection. 

  February 01, 2021

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Dynamic evaluation of hepatocellular carcinoma prediction models in patients with chronic hepatitis B receiving nucleotide/nucleoside analogue treatment. 

  January 23, 2021

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Entecavir-induced interferon-λ1 suppresses type 2 innate lymphoid cells in patients with hepatitis B virus-related liver cirrhosis. 

  January 22, 2021

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Hepatitis C virus cure before hepatocellular carcinoma diagnosis is associated with improved survival. 

  January 22, 2021

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Why do patients with chronic hepatitis C drink alcohol? An examination of pain, depression and drinking motives. 

  January 21, 2021

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Reply to: 'Early HBV RNA kinetics under NA treatment may reveal new insights into HBV RNA dynamics and NA mode of action'. 

  January 18, 2021

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Durability of hepatitis B surface antigen seroclearance and subsequent risk for hepatocellular carcinoma: A meta-analysis. 

  January 17, 2021

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Impact of maternal infection with hepatitis B virus on pregnancy complications and neonatal outcomes for women undergoing assisted reproductive technology treatment: A population-based study. 

  January 16, 2021

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Antiviral treatment for hepatitis C is associated with a reduced risk of atherosclerotic cardiovascular outcomes: A systematic review and meta-analysis. 

  January 16, 2021

  • [ Full-text on Medscape ]
  • [ MEDLINE Abstract ]

• The 48-week safety and therapeutic effects of tenofovir alafenamide in hbv-related acute-on-chronic liver failure: A prospective cohort study. 

  January 10, 2021

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Evaluation of seven rapid diagnostic tests for detection of hepatitis C virus antibodies in China. 

  January 09, 2021

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Risk factors for difficult-to-treat hepatitis C virus genotype 4r in Rwanda and implications for elimination in sub-Saharan Africa. 

  January 09, 2021

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Missed linkage to care for patients who screened positive for Hepatitis C in a tertiary care centre: Results of the Telepass project. 

  January 09, 2021

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Early HBV RNA kinetics under NA treatment may reveal new insights into HBV RNA dynamics and NA mode of action-more detailed kinetic studies are needed. 

  January 01, 2021

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]